Advertisement

Emerging RNAi-Based Therapies for FCS, Dyslipidemia - Episode 1

Familial Chylomicronemia Syndrome: Diagnosis, Genetic Factors, and Long-Term Health Implications

Published on: 
,

Panelists discuss how familial chylomicronemia syndrome (FCS) is characterized by severe hypertriglyceridemia and genetic mutations in the LPL gene, highlighting the key diagnostic criteria and complications, such as acute pancreatitis, while emphasizing the impact of untreated FCS on patient quality of life and long-term health risks.

Video content above is prompted by the following:

  • What is familial chylomicronemia syndrome (FCS), and how can it be distinguished from other forms of hyperlipidemia? What are the key clinical features and diagnostic criteria for FCS?
  • What are the potential complications and long-term health risks associated with untreated FCS?
Advertisement
Advertisement